Merck & Co Inc on Tuesday posted a 10.4per cent rise in first-quarter profit, helped by strong sales of cancer therapy Keytruda, but the drugmaker lowered its 2020 profit forecast due to uncertainty from the COVID-19 pandemic.
Merck profit rises, cuts 2020 forecast over COVID-19 uncertainty
